What evaluation and management are recommended for a 47-year-old woman with irregular menstrual cycles and a recent episode of heavy bleeding?

Evaluation and Management of Perimenopausal Heavy Menstrual Bleeding

A 47-year-old woman with irregular periods and recent heavy bleeding requires immediate pregnancy exclusion, transvaginal ultrasound to rule out structural pathology (especially endometrial cancer), and consideration of endometrial sampling given her age and bleeding pattern. 1, 2

Immediate Assessment

Rule Out Emergent Conditions

• Exclude pregnancy first with urine or serum hCG testing, regardless of perceived likelihood 2
• Assess hemodynamic stability: if bleeding saturates a large pad or tampon hourly for ≥4 hours, this constitutes an emergency requiring urgent evaluation and possible high-dose progestin therapy 3
• Check hemoglobin and iron levels to assess for anemia 2

Initial Diagnostic Workup

• Perform speculum examination to exclude cervical or vaginal sources of bleeding 2
• Order transvaginal ultrasound as the ideal first-line imaging study 1, 2
• Consider thyroid function testing (TSH) as thyroid dysfunction is a common cause of abnormal bleeding in this age group 2, 4

Endometrial Sampling Indications

At age 47, this patient meets criteria for endometrial biopsy due to recurrent anovulatory bleeding in a woman ≥35 years old 4. The risk of endometrial cancer increases significantly in perimenopausal women with abnormal bleeding 2.

When to Perform Endometrial Sampling:

• All women ≥35 years with recurrent anovulation or irregular bleeding 4
• Women with excessive bleeding unresponsive to initial medical therapy 4
• If ultrasound shows endometrial thickness ≥11 mm, endometrial sampling becomes even more critical 3

Imaging Strategy

Transvaginal ultrasound should be performed to evaluate for:

• Endometrial polyps (common in perimenopause) 2
• Leiomyomas (fibroids) 2
• Adenomyosis 2
• Endometrial thickness and irregularities 1

If transvaginal ultrasound cannot adequately visualize the endometrium due to patient body habitus, uterine position, or presence of fibroids/adenomyosis, proceed to MRI with diffusion-weighted imaging 1. Saline infusion sonohysterography can improve diagnostic accuracy when initial ultrasound is equivocal 2.

Medical Management Options

For Acute Heavy Bleeding (Emergency Scenario)

If bleeding is severe (pad/tampon saturation hourly for ≥4 hours), initiate high-dose oral progestin therapy immediately 3:

• Megestrol acetate is particularly effective when endometrial thickness is ≥11 mm 3
• High-dose progestin reduces menstrual blood loss by approximately 87% 3
• This approach is preferred when NSAIDs and tranexamic acid must be avoided due to thrombotic risk 3

For Non-Emergent Heavy Menstrual Bleeding

Once structural pathology and malignancy are excluded, choose from:

First-line options:

• Levonorgestrel-releasing intrauterine system (LNG-IUS 20 μg/day) is the most effective medical therapy, reducing menstrual blood loss by 71-95% 5, 6, 7
• Combined oral contraceptives (if no contraindications) 6
• Tranexamic acid (FDA-approved for ovulatory bleeding) 4, 6, 7

Second-line options:

• Cyclic oral progestins for 21 days per month 4, 6
• NSAIDs during days of bleeding (5-7 days) 8

Important Caveat About Hormonal Therapy

Avoid combined hormonal contraceptives if the patient has cardiovascular risk factors or established cardiovascular disease; in such cases, progestin-only methods are safer 5, 6.

Follow-Up and Reassessment

If bleeding does not improve after initial medical management, reassess for:

• Structural uterine pathology that may have been missed 3
• Coagulation disorders (von Willebrand disease is the most common inherited bleeding disorder causing heavy menstrual bleeding) 9, 7
• Medication interactions or adherence issues 8

Consider referral to gynecology for:

• Hysteroscopic evaluation if polyps or submucous fibroids are suspected 2
• Endometrial ablation if medical management fails and fertility is not desired 4, 6
• Hysterectomy as definitive treatment when all other options have failed 4, 6

Key Clinical Pitfalls to Avoid

• Never assume irregular bleeding in a 47-year-old is "just perimenopause" without excluding endometrial pathology 2, 4
• Do not delay endometrial sampling in women ≥35 years with risk factors for endometrial cancer (obesity, diabetes, chronic anovulation, unopposed estrogen exposure) 4
• Avoid NSAIDs and tranexamic acid in patients with cardiovascular disease or thrombotic risk 5, 3
• Do not prescribe estrogen-containing contraceptives without checking blood pressure and cardiovascular risk factors 8